Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
02/2000
02/22/2000US6027906 Dna molecules coding for the said penicillin binding protein (pbp) variants, as well as vectors containing them; assaying and designing therapeutically useful compounds which have high affinity to pbp
02/22/2000US6027903 Kit for detecting analyte indicative of type I collagen resorption in vivo
02/22/2000US6027901 CYP7 promoter-binding factors
02/22/2000US6027896 Providing a prognosis in subjects previously diagnosed with alzheimer's by identifying the apolipoprotein e type isoforms; then providing prognosis based on the presence or absence of an apolipoprotein e type 4 (apoe4) isoform
02/22/2000US6027888 Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells
02/22/2000US6027887 Screening for preneoplastic/neoplastic disease using a nucleic acid based assay to determine whether mn oncogene expression is present in a vertebrate; and if present, determining if vertebrate is at risk of neoplastic disease
02/22/2000US6027882 Determining genetic predisposition for basal cell carcinoma by detecting a loss-of-function mutation in segment polarity genes; diagnosis of cancer
02/22/2000US6027881 Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
02/22/2000US6027878 A nucleic acid sequence; diagnosis of helicobacter infections, ulcers and gastrointestinal disorders
02/22/2000US6027877 Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, purification of amplified DNA samples and allele identification
02/22/2000US6027876 Method for monitoring pesticide resistance
02/22/2000US6027734 To provide protection against pneumococcal colonization and systemic infection, intranasally administering a composition consisting essentially of pneumococcal surface protein a or a fragment containing a protection-eliciting epitope
02/22/2000US6027729 An isolated polypeptide comprising an amino acid sequence of at least 12 contiguous amino acids encoded by a non-a, non-b hepatitis virus, i.e., hepititis c, genome; managing infection spread; medical diagnosis; evaluation of library
02/22/2000US6027727 Inducing transient infertility in a mammal by administering a dose of recombinant zona pellicida proteins from a cat, cattle or cynomolgous monkey and human to stimulate antibody production; vaccines
02/22/2000US6027720 G-CSF conjugate
02/22/2000US6027648 A separating agent comprising a stationary phase in which ovomucoid part of which has been modified and a carrier on which the modified ovomucoid has been immobilized, contacting the separating agent with the mixture of optical isomers
02/22/2000US6027565 Method and apparatus for crystalizing macromolecules in microgravity
02/22/2000CA2091882C Gene therapy for cystic fibrosis
02/22/2000CA2071630C Hybrid protein c
02/22/2000CA2071625C A pharmaceutical preparation containing a thrombolytically active substance
02/22/2000CA2024101C Polymer compositions
02/22/2000CA2004532C Peptide derivatives
02/22/2000CA2003455C Immunotherapy involving cd28 stimulation
02/22/2000CA1340910C Fibronectin binding protein
02/22/2000CA1340908C Methods of producing secreted receptor analogs and biologically active peptide dimers
02/22/2000CA1340907C Synthetic antigen evoking anti-hiv responese
02/22/2000CA1340906C Fibronectin binding protein as well as its preparation
02/19/2000CA2245340A1 Traf4-associating protein
02/17/2000WO2000008469A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease
02/17/2000WO2000008444A1 Fluorescent assay for biological systems
02/17/2000WO2000008443A1 Multiple frequency fluorescence lifetime imaging
02/17/2000WO2000008206A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer
02/17/2000WO2000008199A1 Molecular cloning of a 7tm receptor (gpr31a)
02/17/2000WO2000008189A2 Plant resistance gene
02/17/2000WO2000008188A1 Transformed plant cell with at least the coding part of the gene coding for fibrillin
02/17/2000WO2000008187A2 Genes involved in tolerance to environmental stress
02/17/2000WO2000008182A1 Herpesvirus preparations and their uses
02/17/2000WO2000008181A2 Chp polypeptide, a ligand of pak65
02/17/2000WO2000008174A1 β-CASEIN EXPRESSING CONSTRUCTS
02/17/2000WO2000008168A1 Improvements to strains of streptomyces through the use of biosynthetic genes of tylosine
02/17/2000WO2000008167A1 Trimer of hiv env gene expression product
02/17/2000WO2000008165A1 Attenuated equine herpesvirus
02/17/2000WO2000008164A2 Thermostable in vitro complex with polymerase activity
02/17/2000WO2000008162A1 A Pi-ta GENE CONFERRING DISEASE RESISTANCE TO PLANTS
02/17/2000WO2000008161A1 Transgenic plants with the expression of soybean glycinin
02/17/2000WO2000008160A2 A plant disease resistance signalling gene: materials and methods relating thereto
02/17/2000WO2000008159A2 Production and use of modified cystatins
02/17/2000WO2000008158A2 Molecules designated ldcam
02/17/2000WO2000008157A2 Human anion transporter genes atnov
02/17/2000WO2000008156A2 Dna replication- and repair-associated proteins
02/17/2000WO2000008155A2 Human receptor-associated proteins
02/17/2000WO2000008154A1 Pancreatic and ovarian polypeptide, zsig58
02/17/2000WO2000008153A2 Arf-p19, a novel regulator of the mammalian cell cycle
02/17/2000WO2000008152A1 Novel orphan cytokine receptors
02/17/2000WO2000008151A1 Calcium/calmodulin dependent kinase and an alternative splice product thereof
02/17/2000WO2000008149A2 Human neuronal acid-sensitive cationic channels, its cloning and applications
02/17/2000WO2000008148A1 Nucleic sequences coding for an at2 interacting protein interacting with the at2 receptor and their applications
02/17/2000WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses
02/17/2000WO2000008146A2 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents
02/17/2000WO2000008145A2 Novel genes in control of hematopoiesis
02/17/2000WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3
02/17/2000WO2000008143A2 Gene isolated on the short arm of human chromosome 17
02/17/2000WO2000008142A2 Fibrous proteins and the production thereof
02/17/2000WO2000008141A2 Short oligonucleotides for the inhibition of vegf expression
02/17/2000WO2000008139A1 Tumor necrosis factor-gamma
02/17/2000WO2000008137A2 Transgenic animals having a modified glycoprotein v gene
02/17/2000WO2000008133A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE
02/17/2000WO2000008131A2 Pseudotyped retroviruses and stable cell lines for their production
02/17/2000WO2000008057A2 Molecules designated b7l-1
02/17/2000WO2000008056A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
02/17/2000WO2000008055A1 A human vamp-2 like gene (cbcbmh06)
02/17/2000WO2000008054A1 Modified green fluorescent protein
02/17/2000WO2000008053A1 Novel g-protein coupled receptor protein and dna thereof
02/17/2000WO2000008052A1 A novel retinal nuclear hormone receptor
02/17/2000WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof
02/17/2000WO2000008050A1 Dna encoding human monocyte-macrophage apolipoprotein b receptor gene and protein
02/17/2000WO2000008045A2 Novel molecules of the tango-93-related protein family and uses thereof
02/17/2000WO2000008043A2 Prevention and treatment of viral disease
02/17/2000WO2000007632A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
02/17/2000WO2000007631A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
02/17/2000WO2000007622A1 Attenuated poliovirus vaccine
02/17/2000WO2000007618A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof
02/17/2000WO2000007617A1 Use of glp-1 and analogues for preventing type ii diabetes
02/17/2000WO2000007614A1 Remedies for nerve degeneration diseases
02/17/2000WO2000007611A1 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides
02/17/2000WO2000007610A1 Interacting proteins for autoantigens of autoimmune diseases
02/17/2000WO2000007609A1 Peptide antagonists of zonulin and methods for use of the same
02/17/2000WO2000007545A2 Apoptosis proteins
02/17/2000WO2000007438A1 Use of an animal model deficient in p53 and having memory deficiency and/or behavioural disorders for therapeutic purposes
02/17/2000WO2000007431A1 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof
02/17/2000WO2000007427A2 Method for selective and optionally reversible degeneration of somatic plant tissue
02/17/2000WO2000001815A3 Neurotrophic factors
02/17/2000WO2000001720A3 Compositions and methods for treating papillomavirus-infected cells
02/17/2000WO1999065942A8 Cyclic somatostatin analogs
02/17/2000WO1999064451A3 Plant protein with repeated wd40 motifs, nucleic acid coding for said protein, and uses thereof
02/17/2000WO1999062932A3 INHIBITION OF VIRAL INFECTION AND SPREAD WITH VIRAL AND RhoA-DERIVED PEPTIDES
02/17/2000WO1999062534B1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS
02/17/2000WO1999061613A3 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions
02/17/2000WO1999061601A3 Aav5 vector and uses thereof
02/17/2000WO1999060110A9 Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy